Tissue Procurement Protocol for the Developmental Therapeutics Clinic National Cancer Institute (NCI)
A
Anna Maria Storniolo, MD
Primary Investigator
Overview
The purpose of this study is to obtain samples for research purposes from tests performed for clinical indications or research indications on other research protocols, and to obtain samples for research purposes from non-surgical procedures, performed for the sole purpose of obtaining samples for this protocol.
Description
The purpose of this study is to obtain samples for research purposes from tests performed for clinical & research indications on other research protocols and to obtain samples for research purposes from non-surgical procedures, such as percutaneous biopsies, performed for the sole purpose of obtaining tissue specimens or biological fluids for this protocol.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Cancer, Neoplasms, Lymphoma, Multiple Myeloma
-
Age: - 110 Years
-
Gender: All
Inclusion Criteria
In order to be eligible to take part in this trial, patients must meet the following criteria:
- Patients who are being evaluated for and or treated at the NIH Clinical Center or at participating sites.
- Ability to understand and willingness to sign a written informed consent document indicating their willingness to have their tissue or biologic fluid specimens used for research as outlined in this protocol.
- Age greater than 18 years
For a full list of participation criteria, please visit ClinicalTrials.gov.
Updated on
27 Apr 2024.
Study ID: 1407712395 (CC06-C-0213)
Connect with a study center near you
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact